News
Innovative blood test boosts accuracy of lung cancer screening
In a recent study published in Cancer Discovery, researchers developed and validated a blood-based, cell-free deoxyribonucleic acid (cfDNA) fragmentome assay for lung cancer detection, which, if the results were positive, would be followed by low-dose computed tomography (LDCT). Study: Clinical validation of a cell-free DNA fragmentome assay for augmentation of lung cancer early detection. Image Credit: MMD […]